Castagna Michael

Chief Executive Officer, Director

Avg. Two Year Performance

(57%) Avg. Purchase Return    (25%) Compound
No Sale Track Record

Holdings: 1.11M shares

Last Three Months: 21-Jun-20 -- 20-Sep-20

$6.25K Net Amount
Buy:$6.25K$1.25
Sell:0--

Sentiment

Insider Trading Sentiment: Accumulate

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

21-Sep-18 -- 20-Sep-20

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions